Perspektiver på recidiverende respiratorisk papillomatose og humant papillomvirus-vaccination

Simone Trolle; Charlotte Duch Lynggaard; Kristine Grubbe Gregersen; Louise Baandrup; Christian Grønhøj; Christian von Buchwald

Perspektiver på recidiverende respiratorisk papillomatose og humant papillomvirus-vaccination

Simone Trolle, Charlotte Duch Lynggaard, Kristine Grubbe Gregersen, Louise Baandrup, Christian Grønhøj, Christian von Buchwald

Publikation: Bidrag til tidsskrift › Review › Forskning › peer review

Abstract

Recurrent respiratory papillomatosis (RRP) is a condition with benign tumours in the respiratory tract. RRP ensues in both children and adults. The disease is induced by low-risk human papillomavirus (HPV) types HPV-6 and HPV-11. RRP have a recurrent nature with symptoms ranging from hoarseness, dyspnoea, and dysphagia to life-threatening airway obstructions. Currently, no medical curative treatment of RRP is available, however, the literature indicates, that the HPV-vaccines could protect against RRP by preventing genital warts.

Bidragets oversatte titel	Perspectives on recurrent respiratory papillomatosis and human papillomavirus
Originalsprog	Dansk
Artikelnummer	V05190279
Tidsskrift	Ugeskrift for laeger
Vol/bind	181
Status	Udgivet - 7 okt. 2019

Emneord

Adult
Child
Humans
Papillomavirus Infections/diagnosis
Papillomavirus Vaccines/therapeutic use
Respiratory Tract Infections/diagnosis

Adgang til dokumentet

https://ugeskriftet.dk/videnskab/perspektiver-pa-recidiverende-respiratorisk-papillomatose-og-humant-papillomvirus

Citationsformater

@article{ff42cd3e9daf496684f8a0a4b84151f0,

title = "Perspektiver p{\aa} recidiverende respiratorisk papillomatose og humant papillomvirus-vaccination",

abstract = "Recurrent respiratory papillomatosis (RRP) is a condition with benign tumours in the respiratory tract. RRP ensues in both children and adults. The disease is induced by low-risk human papillomavirus (HPV) types HPV-6 and HPV-11. RRP have a recurrent nature with symptoms ranging from hoarseness, dyspnoea, and dysphagia to life-threatening airway obstructions. Currently, no medical curative treatment of RRP is available, however, the literature indicates, that the HPV-vaccines could protect against RRP by preventing genital warts.",

keywords = "Adult, Child, Humans, Papillomavirus Infections/diagnosis, Papillomavirus Vaccines/therapeutic use, Respiratory Tract Infections/diagnosis",

author = "Simone Trolle and Lynggaard, {Charlotte Duch} and Gregersen, {Kristine Grubbe} and Louise Baandrup and Christian Gr{\o}nh{\o}j and Buchwald, {Christian von}",

year = "2019",

month = oct,

day = "7",

language = "Dansk",

volume = "181",

journal = "Ugeskrift for laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

}

TY - JOUR

T1 - Perspektiver på recidiverende respiratorisk papillomatose og humant papillomvirus-vaccination

AU - Trolle, Simone

AU - Lynggaard, Charlotte Duch

AU - Gregersen, Kristine Grubbe

AU - Baandrup, Louise

AU - Grønhøj, Christian

AU - Buchwald, Christian von

PY - 2019/10/7

Y1 - 2019/10/7

N2 - Recurrent respiratory papillomatosis (RRP) is a condition with benign tumours in the respiratory tract. RRP ensues in both children and adults. The disease is induced by low-risk human papillomavirus (HPV) types HPV-6 and HPV-11. RRP have a recurrent nature with symptoms ranging from hoarseness, dyspnoea, and dysphagia to life-threatening airway obstructions. Currently, no medical curative treatment of RRP is available, however, the literature indicates, that the HPV-vaccines could protect against RRP by preventing genital warts.

AB - Recurrent respiratory papillomatosis (RRP) is a condition with benign tumours in the respiratory tract. RRP ensues in both children and adults. The disease is induced by low-risk human papillomavirus (HPV) types HPV-6 and HPV-11. RRP have a recurrent nature with symptoms ranging from hoarseness, dyspnoea, and dysphagia to life-threatening airway obstructions. Currently, no medical curative treatment of RRP is available, however, the literature indicates, that the HPV-vaccines could protect against RRP by preventing genital warts.

KW - Adult

KW - Child

KW - Humans

KW - Papillomavirus Infections/diagnosis

KW - Papillomavirus Vaccines/therapeutic use

KW - Respiratory Tract Infections/diagnosis

M3 - Review

C2 - 31610833

SN - 0041-5782

VL - 181

JO - Ugeskrift for laeger

JF - Ugeskrift for laeger

M1 - V05190279

ER -

Perspektiver på recidiverende respiratorisk papillomatose og humant papillomvirus-vaccination

Abstract

Emneord

Adgang til dokumentet

Fingeraftryk

Citationsformater